FDA warns American CryoStem Corporation of significant deviations related to its unapproved stem cell product, Atcell – FDA.gov
|
FDA warns American CryoStem Corporation of significant deviations related to its unapproved stem cell product, Atcell
FDA.gov The U.S. Food and Drug Administration today posted a warning letter issued to American CryoStem Corporation of Monmouth Junction, New Jersey, and its Chairman/Chief Executive Officer, John S. Arnone, for marketing an adipose derived stem cell product … |
